News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lundbeck Inc. (LUN.CO) Release: ONFI® (clobazam) CIV Scored Tablets and Oral Suspension Now Available in U.S. Pharmacies


8/12/2013 9:58:35 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck announced today that ONFI (clobazam) CIV will be available in scored tablet and oral suspension formulations beginning this week. These new formulations were recently approved by the U.S. Food & Drug Administration (FDA). ONFI is a prescription medication originally approved by the FDA in 2011, and is used along with other medicines to treat seizures associated with Lennox-Gastaut syndrome (LGS) in adults and children 2 years of age or older.1 ONFI is an oral anti-epileptic drug (AED) of the benzodiazepine class, and is a 1,5 benzodiazepine.1 It is a federally controlled schedule four substance (CIV).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES